Cargando…
Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study
BACKGROUND: Whether or not the use of metformin decreases the risk of gastric adenocarcinoma is unclear. METHODS: This was a population-based cohort study in 2005–2015. Associations between metformin use and gastric non-cardia and cardia adenocarcinomas were examined within two cohorts; a diabetes c...
Autores principales: | Zheng, Jiaojiao, Xie, Shao-Hua, Santoni, Giola, Lagergren, Jesper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889304/ https://www.ncbi.nlm.nih.gov/pubmed/31591459 http://dx.doi.org/10.1038/s41416-019-0598-z |
Ejemplares similares
-
Prediabetes and diabetes in relation to risk of gastric adenocarcinoma
por: Zheng, Jiaojiao, et al.
Publicado: (2019) -
Cohort profile: the Swedish Prescribed Drugs and Health Cohort (SPREDH)
por: Xie, Shao-Hua, et al.
Publicado: (2019) -
Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study
por: Wang, Qiao-Li, et al.
Publicado: (2023) -
Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis
por: Zheng, Jiaojiao, et al.
Publicado: (2022) -
Correction: Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis
por: Zheng, Jiaojiao, et al.
Publicado: (2022)